TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 1 | -4 | 2 | -19 | -64 | -70 | -26 |
| S | %wins | 0 | 100 | 0 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/15 17:47 | 11/19/15 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Danilkovitch Alla | MD | O | Chief Sc | M.d | 20 | 5.08 | 5 | 4 | 50 | 12 | D | -29 | -19 | -41 | -39 | -37 | -38 | -26 | -24 | -5 | -3 | 1 | -32 | -53 | -39 |
8/11/15 06:32 | 8/10/15 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Danilkovitch Alla | MD | O | Chief Sc | M.d | 2 | 0.4000 | 5 | 5 | 169 | 8 | D | 76 | 23 | 21 | 6 | -3 | -17 | -13 | -3 | 1 | -4 | 2 | -19 | -64 | -70 |
8/11/15 06:32 | 8/10/15 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Danilkovitch Alla | MD | O | Chief Sc | S.d | -44 | 18.22 | 5 | -2 | -23 | 8 | D | 76 | 23 | 21 | 6 | -3 | -17 | -13 | -3 | 1 | -4 | 2 | -19 | -64 | -70 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |